Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GmHelixImplant,Ti,6.0X10mm: medical device reports filed with FDA

690 reports name it, 2019–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

690
device reports naming the brand
0% of all MAUDE reports · about 100 a year
191
reports, 12 months to August 2026
142 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 690 reports that name the brand "GmHelixImplant,Ti,6.0X10mm" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

191 reports arrived in the 12 months to August 2026, up 35% from 142 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (68%), loss of osseointegration (10.9%) and difficult to insert (4.9%). The patient problems coded most often are fibrosis, pain and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01427Sep 2021: 0Oct 2021: 6Nov 2021: 4Dec 2021: 02022Jan 2022: 6Feb 2022: 3Mar 2022: 5Apr 2022: 11May 2022: 10Jun 2022: 9Jul 2022: 15Aug 2022: 3Sep 2022: 3Oct 2022: 8Nov 2022: 10Dec 2022: 52023Jan 2023: 6Feb 2023: 10Mar 2023: 10Apr 2023: 2May 2023: 20Jun 2023: 11Jul 2023: 11Aug 2023: 13Sep 2023: 17Oct 2023: 9Nov 2023: 9Dec 2023: 22024Jan 2024: 6Feb 2024: 13Mar 2024: 15Apr 2024: 17May 2024: 14Jun 2024: 12Jul 2024: 11Aug 2024: 4Sep 2024: 12Oct 2024: 6Nov 2024: 19Dec 2024: 122025Jan 2025: 9Feb 2025: 18Mar 2025: 6Apr 2025: 2May 2025: 0Jun 2025: 25Jul 2025: 14Aug 2025: 19Sep 2025: 18Oct 2025: 22Nov 2025: 11Dec 2025: 212026Jan 2026: 12Feb 2026: 13Mar 2026: 12Apr 2026: 11May 2026: 17Jun 2026: 13Jul 2026: 27Aug 2026: 14

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0831652019: 520192020: 1020202021: 4220212022: 8820222023: 12020232024: 14120242025: 16520252026: 1192026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%690
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report74.3%513
Voluntary report0%0
User facility report0%0
Distributor report25.7%177
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate46968%62.8%
Loss of osseointegration7510.9%22.4%
Difficult to insertthe device was hard to insert344.9%0.4%
Fracturea broken bone81.2%1.6%
Separation failure60.9%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis16023.2%
Painpain, site not specified14320.7%
Hemorrhage/blood loss/bleeding568.1%
Inflammationinflammation415.9%
Swelling/ edema385.5%
Abscessa collection of pus192.8%
Hyperresponsive to stimuli121.7%
Fistula111.6%
Hypersensitivity/allergic reaction111.6%
Numbnessnumbness40.6%
Sinus perforation10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGmHelixImplant,Ti,6.0X10mmProduct code DZEAll MAUDE reports
Reports6903,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer74.3%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GmHelixImplant,Ti,6.0X10mm reports

How many FDA reports name GmHelixImplant,Ti,6.0X10mm?

690 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 191 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (68%), loss of osseointegration (10.9%), difficult to insert (4.9%), fracture (1.2%) and separation failure (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (74.3%) and distributor reports (25.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GmHelixImplant,Ti,6.0X10mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.